Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.
Wentzensen, Nicolas; Walker, Joan; Schiffman, Mark; Yang, Hannah P; Zuna, Rosemary E; Dunn, S Terence; Allen, R Andy; Zhang, Roy; Sherman, Mark; Gold, Michael A; Wang, Sophia S.
Int J Cancer
; 132(1): 148-54, 2013 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-22488167
Cytology versus HPV testing for cervical cancer screening in the general population.
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
[Relationship between cervical lesions and the type-specific viral load of high risk HPV reflected by the Ct value of Cobas 4800 HPV system].
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.
Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
[Study on Dynamic Changes of Human Papillomavirus 16 <i>E5</i> Gene in the Occurrence of Cervical Cancer].
Risk factors of persistent HPV infection after treatment for high-grade squamous intraepithelial lesion.
Retinoids for preventing the progression of cervical intra-epithelial neoplasia.
Justifying conservative management of CIN2 in women younger than 25â¯years - A population-based study.